FindTrial
Sign In

A study on the effect of Homoeopathic medicine Solanum lycopersicum 30 (Tomato) in the treatment of patients with Allergic rhinitis

Evidence based interventional study on efficacy of Homoeopathic remedy Solanum lycopersicum 30 in the management of Allergic rhinitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024215
Enrollment
30
Registered
2020-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Homoeopathic remedy Solanum lycopersicum 30: Homoepathic remedy Solanum lycopersicum 30 , will be prescribed to patients of allergic rhinitis 4 pills twice daily orally for 3 months wit

Sponsors

Cheif of research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of Allergic rhinitis of minimum 1-year duration. 2.Both intermittent (seasonal and perennial) and persistent varieties of Allergic rhinitis, both mild and moderate to severe Allergic rhinitis.

Exclusion criteria

Exclusion criteria: 1.Cases with gross nasal developmental defects or structural abnormalities causing obstruction, e.g. nasal polyps, deviated septum. 2.Respiratory infection, cases with severe/uncontrolled bronchial asthma, •Presence of severe systemic diseases like cardiovascular, endocrinal, renal etc., •Pregnancy, breast feeding, •Oral or parenteral steroids or decongestant in past 6 months

Design outcomes

Primary

MeasureTime frame
Serum IgE levels Absolute Eosinophil CountTimepoint: 3 months post intervention—

Secondary

MeasureTime frame
Changes in serum Ig E and Absolute Eosinophil Count and intensity of symptomsTimepoint: 3months—

Countries

India

Contacts

Public ContactDr Heleena Famla Dsouza

Father Muller Homoeopathic Medical College

cheriyanraisa@gmail.com8050230823

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026